Caplight Directory>Investors>Nan Fung Life Sciences>Nan-fung-life-sciences


Nan Fung Life Sciences

Nan Fung Life Sciences

Hong Kong SARnanfung.com

Overview

Nan Fung Life Sciences (NFLS) is the global investment platform of the Nan Fung Group, a Hong Kong-based conglomerate. Founded in 2017, it focuses on the life sciences sector, making direct investments (via its Pivotal bioVenture Partners funds) and fund investments. Its investment scope covers the full spectrum of the industry, including therapeutics, medical devices, and diagnostics, across various development stages, with a presence in the US and Greater China.

Portfolio Companies

8

Investments

CompanyDateStageLead
Aboz PharmaceuticalsNov 2021Series ACo-investor
Fountain TherapeuticsNov 2021Series A ExtensionCo-investor
Engrail TherapeuticsAug 2021Series A ExtensionLead
Arctic VisionMar 2021Series BCo-investor
EncodiaJan 2021Series CCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHong Kong SAR
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.